Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB

Lawsuit filings and inter partes review petitions both fell in 2018, but operating companies’ share of the action was on the rise 

Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB
18 Jan 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

18 Jan 2019

US prosecutors may resurrect trade secrets charges against Huawei

The Department of Justice is considering charging Huawei with stealing trade secrets related to a phone testing robot developed by T-Mobile . But in a 2014 civil trial on the same issues, the US carrier’s punches failed to land

Featured

17 Jan
2019

As the FTC rests its case against Qualcomm it’s advantage Apple at the PTAB

Series of IPRs instituted against chipmaker’s patents including against patent that was subject of controversial ITC ruling Read more

17 Jan
2019

University domination of the biologics patent landscape points way to heightened deal-making in the coming years

New report shows research institutions dominate the field, with UCAL, Johns Hopkins, Stanford, the NIH, Harvard and Singapore’s Agency for Science Technology & Research leading the way between 2015 and 2018 Read more

17 Jan
2019

Chinese Airpod assembler picks up patents from Panasonic

GoerTek’s billionaire founder modeled his business on Panasonic from day one. Now “China’s Bluetooth king” is buying patents from the Japanese company Read more

News

View all
16 Jan 2019

New collaboration between leading IP brands set to boost global patent transactions

IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers Read more

16 Jan 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so Read more

15 Jan 2019

Indian IP jurisprudence is the real winner in the Monsanto cotton technology case

Supreme Court decision does not bring any clarity to the technical issues at stake, but it does establish clear rules for how judges should handle complex patent suits Read more

13 Jan 2019

US patent sales up, Monsanto wins big in India, Sisvel and RPX ink major SEP deal, the global patent market in 10 charts - plus much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one Read more

Analysis

View all
15 Jan 2019

Latest lawsuits underline importance of TiVo’s patent battle with Comcast

The TV guide technology business has accused the cable giant of infringing eight of its rights as talk again turns to a possible sell-off of the products business in order to focus entirely on licensing Read more

15 Jan 2019

Coolpad CEO removed after lamenting lax IP enforcement in China

The executive who charted a new course for the company based in part on patent monetisation sounded disillusioned with China’s IP system days before his ouster Read more

14 Jan 2019

Pool operator questions "fatally flawed" Unified Patents study on HEVC royalty rates

Research was released as a new industry forum met in Silicon Valley to discuss the potential of a different approach to licensing the next video codec standard Read more

14 Jan 2019

The ultimate success of the Bristol-Myers’ Celgene purchase could hinge on one upcoming trial

Biggest life sciences M&A deal for nearly two decades may turn out to be a damp squib if Dr Reddy’s wins a suit relating to follow-on patents that cover flagship cancer treatment Revlimid   Read more

Events

View all
28 Jan
2019
Latest

Pharma & Biotech IP 2019

With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation. This event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.

27-28 March
2019
Latest

IPBC Europe 2019

In the era of the fourth industrial revolution (4IR), European companies are faced with a number of exciting opportunities – but also significant IP challenges. Designed by and for European IP owners, the programme for IPBC Europe 2019 will explore how IP managers inside the continent’s businesses can devise and build sustainable value creation programmes in the rapidly changing world.

16-18 June
2019
Latest

IPBC Global 2019

The leading gathering of global IP decision makers and thought-leaders returns to Boston! As the fourth industrial revolution gathers pace, IPBC Global’s 2019 programme explores the key IP issues this new era of change and innovation presents for corporate leaders, policy makers, investors, the legal profession and third-party service providers.

Insights

30 Nov 2018

IP market news highlights

Some of the major stories carried on the IAM platform in October and November. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

27 Sep 2018

IP market news highlights

Some of the major stories carried on the www.IAM-media.com platform in August and September Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our unique and timely intelligence service informs commercial trademark decision making in boardrooms globally by translating trademark law into business sense.